Invest In Intelligent Sleep Technology
.webp)
Sleep Deprivation Is An Epidemic
According to the CDC, sleep deprivation is a public health concern. And while Americans spend billions on sleep aids, most don’t work or have negative side effects.
Patented Sleep Solution
Our Intelligent Release Technology™ combats sleep deprivation with proprietary formulations that release all-natural sleep ingredients in 3 phases.
A 3-Phase Process
1
Capsule dissolves and a controlled quantity of ingredients enters the body to promote relaxation: Magnesium, L-Tryptophan, Casein Decapeptide, Melatonin
2
Over the next 2.5 hours, beads absorb water until it’s time to release a new round of ingredients
3
Over the next 4 hours, beads burst & release precisely measured ingredients for sleep duration: Hops, Valerian root, Lemon balm, Magnolia, Melatonin
Ingredients
A mineral that aids the sleeping process by activating the parasympathetic nervous system, which is responsible for getting you calm and relaxed.
An herb that comes from the same family as mint, traditionally used to improve mood and cognitive function.
An essential amino acid that helps maintain sleep-wake cycles and promotes healthy levels of serotonin and melatonin
A plant containing compounds that raise GABA and serotonin, which work to soothe the central nervous system and regulate the body's circadian rhythm.
A flowering tree used in traditional Chinese, Japanese, and Korean medicine to promote sleep and relaxation, ease anxiety and treat allergies and asthma.
An herb containing compounds that can act on the GABA receptors, which are responsible for sleep regulation.
Melatonin is a natural hormone made by the pineal gland. During the day the pineal is inactive. When the sun goes down and darkness occurs, the pineal is turned on by the CNS and begins to actively produce melatonin, which is released into the blood. Usually, this occurs around 9 pm. As a result, melatonin levels in the blood rise sharply and you begin to feel less alert.
Casein Decapeptide is a milk-derived protein fraction that helps modulate stress and improve sleep by promoting healthy neural activity, relieving occasional stress, and reducing the time to fall asleep.
Magnesium
A mineral that aids the sleeping process by activating the parasympathetic nervous system, which is responsible for getting you calm and relaxed.
Lemon Balm
An herb that comes from the same family as mint, traditionally used to improve mood and cognitive function.
L-Tryptophan
An all-natural ingredient made from cow’s milk proteins that contains a bioactive decapeptide with proven relaxing properties.
Hops
A plant containing compounds that raise GABA and serotonin, which work to soothe the central nervous system and regulate the body's circadian rhythm.
Magnolia
A flowering tree used in traditional Chinese, Japanese, and Korean medicine to promote sleep and relaxation, ease anxiety and treat allergies and asthma.
Valerian Root
An herb containing compounds that can act on the GABA receptors, which are responsible for sleep regulation.
Our Expansion Pipeline
We have modeled to 3.4% share, which is a $100M business, by 2026.
Phase 1
e-Commerce Launch
2023
Phase 2
Retail Launch
2024
Phase 3
Big Box Retail Expansion
2025
Market Traction
Notable companies are working with Nightwise
Partner
Investor
Partner
Partner
Americans Need Sleep. Here’s How We Help.
98% order fulfillment
in 2-3 business days
in 2-3 business days
Patent Status Granted For Time Release Sleep Aid System In 2022 (U.S. Pat. 11,351,150)
Top 4% digital launch performance on Facebook nationwide during launch week
Future
Opportunities
Product Optimization
Conduct clinical trials to investigate product efficacy & continue optimizing formulas
Expansion
Develop additional line extensions (daytime energy, performance, naps, etc.).
Exit Ready
Building a sustainable, consumer health company creates an enormous potential exit opportunity.
Invest In Intelligent Sleep Technology
NightWise® is projected to become a market leader in the $80 billion U.S. sleep industry1 with proprietary, controlled-release sleep solutions.
Formula Innovation
Danny Rinaldi, Founder of NightWise®, developed sleep problems due to jet lag. Everything he tried either didn’t work or had negative side effects, so he set out to create his own solution. Danny ultimately partnered with the nation's leading nutraceutical scientist to create the now patented formula that works with our bodies natural sleep cycles.
NightWise
Management Team
Danny Rinaldi
Founder & CEO
Danny Rinaldi founded NightWise, LLC in January of 2011 and has been serving as CEO, President, and Chief Operating Officer since the inception of the company. For the last twenty-two years, Danny has been an entrepreneurial executive in early-stage startups in various industries, developing multi-million-dollar brands and managing fast-paced, high-growth, private businesses. Danny has been featured in The Million Mind, a top-selling book by Dr. Thomas J. Stanley, as one of the country's top salespeople and featured on the front pages of the Wall Street Journal Business section and The Atlanta Journal-Constitution.
Scott Forsberg
Chief Innovation Officer
Scott Joined NightWise in 2015 as co-creator of NightWise’s Intelligent Release TechnologyTM. A microbiologist by training, Scott has a 30-year history of creating health-centric products and companies. He has made a career out of maximizing the value of technological and branding assets in healthcare industries by serving in various C- suite and board level positions.
Ed Klein
Chief Marketing Officer
Ed is the CMO of NightWise and has led all key aspects of the brand's development since its inception. Prior to Ed’s involvement with NightWise, he had a 30+ year career in the Marketing and Advertising world; including a tenure at Coca-Cola as Global Advertising Director for brand Coke and VP Marketing Diet Coke. Following that, he was the principal at two independent ad agencies.
Stephen Gross
CPA, CGMA, CVA, CFE, CFO
and Director of Finance
Steve began his career with an International Accounting and Consulting Firm rising to the position of National Director of Business Advisory Services and member of the firm's Executive Committee. After the merger with another firm, he co-founded HLB Gross Collins, PC, a regional firm representing private companies across the US and offshore. He currently serves on a Franklin Templeton Independent Board as an audit committee principal. He co-founded Trusted CFO Solutions, a Virtual CFO and outsourced accounting Firm, and Gross Capital Partners, a Financial Advisory Firm.
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. The Company has filed a Regulation D, 506(c) offering with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here.
FAQs
Why invest in startups?
Early-stage investing allows investors to support startups and early-growth companies that they are passionate about. This is different from helping a company raise money on Kickstarter. With Regulation D, 506(c) Offerings, you aren’t buying products or merchandise. You are buying a piece of a company and helping it grow.
How much can I invest?
This Regulation D, 506(c) offering is limited to accredited investors only, and the offering is capped at $1,000,000.00. Rule 506 (c) offerings are private placements that allow issuers to raise unlimited capital from accredited investors. An accredited investor is an individual or entity with a high net worth or income, as defined by the US Securities and Exchange Commission (SEC). There is no fixed limit to the amount that an accredited investor can invest in a Rule 506 (c) offering.
Am I an accredited investor?
An accredited investor is an individual or entity deemed to have sufficient financial knowledge, experience, and net worth to invest in securities not registered with the Securities and Exchange Commission (SEC). To meet the criteria of an accredited investor, an individual must have a net worth of at least $1 million (excluding their primary residence) or an annual income of at least $200,000 for the previous two years ($300,000 for married couples). Entities such as investment companies, banks, and partnerships with assets of at least $5 million are also considered accredited investors. Accredited investors have access to investment opportunities that are not available to the general public, such as private equity funds, venture capital, and hedge funds. This classification protects less experienced investors from taking on too much risk when investing in high-risk securities.
What are the tax implications of an equity crowdfunding investment
We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.
What are the tax implications of an equity crowdfunding investment?
We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.
Who can invest in a Regulation D, 506 (c) Offering?
Only individuals over 18 years of age who are accredited investors can invest.
What do I need to know about early-stage investing? Are these investments risky?
Investing in startups and small businesses is inherently risky and standard company risk factors such as execution and strategy risk are often magnified at the early stages of a company. In the event that a company goes out of business, your ownership interest could lose all value. Furthermore, private investments in startup companies are illiquid instruments that typically take up to five and seven years (if ever) before an exit via acquisition, IPO, etc.
When will I get my investment back?
NightWise, LLC is a privately held company, and its shares are not traded on a public stock exchange. As a result, the shares cannot be easily traded or sold. As an investor in a private company, you typically receive a return on your investment under the following two scenarios: The company gets acquired by another company. The company goes public (makes an initial public offering on the NASDAQ, NYSE, or another exchange). In those instances, you receive your pro-rata share of the distributions that occur, in the case of acquisition, or you can sell your shares on the exchange. It can take 5-7 years (or longer) to see a distribution or trading, as it takes years to build companies. In many cases, there will not be any return as a result of business failure. Investments in private placements and start-up investments in particular are speculative and involve a high degree of risk, and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investments tend to be in earlier stages of development, and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors on Regulation D, 506 (c) offerings will receive securities that are subject to holding period requirements. The most sensible investment strategy for start-up investing may include a balanced portfolio of different start-ups. Start-ups should only be part of your overall investment portfolio. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.
Can I sell my shares?
Shares sold via Regulation D, 506(c) offerings have a one-year lock-up period before those shares can be sold under certain conditions.
Exceptions to limitations on selling shares during the one-year lock up are transfers:
- to the company that issued the securities; - to an accredited investor; - to a family member (defined as a child, stepchild, grandchild, parent, stepparent, grandparent, spouse or spousal equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships.); - in connection with your death or divorce or other similar circumstance;
What happens if a company does not reach their funding goal?
This Regulation D, 506(c) offering requires a minimum threshold of $50,000.00 for the funds to be released. If the company does not reach its total goal of $1,000,000.00 through this round of offering, it will pursue alternative funding sources. It is imperative that potential investors carefully look into the details of this Regulation D, 506(c) offering before investing.
How can I learn more about a company's offering?
All available financial information can be found on the offering pages for the company’s Regulation D, 506(c) offering.
What if I change my mind about investing?
You may cancel your investment at any time, for any reason until 48 hours prior to a closing occurring. If you have already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To submit a request to cancel your investment please email investsupport@nightwise.com
Invest In Intelligent Sleep Technology
NightWise® is projected to become a market leader in the $80 billion U.S. sleep industry1 with proprietary, controlled-release sleep solutions.
Join the Discussion